Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study

M Cruijsen; W J F M van der Velden; A F J de Haan; S K Klein; M Hoogendoorn; Y Tromp; B de Valk; B van Rees; F de Boer; E van der Spek; J Pruijt; L F Verdonck; E Vellenga; N Blijlevens; A A van de Loosdrecht; G Huls

doi:10.1080/10428194.2020.1775217

Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study

M Cruijsen^*, W J F M van der Velden, A F J de Haan, S K Klein, M Hoogendoorn, Y Tromp, B de Valk, B van Rees, F de Boer, E van der Spek, J Pruijt, L F Verdonck, E Vellenga, N Blijlevens, A A van de Loosdrecht, G Huls

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	2752-2755
Number of pages	4
Journal	Leukemia & Lymphoma
Volume	61
Issue number	11
Early online date	1-Jun-2020
DOIs	https://doi.org/10.1080/10428194.2020.1775217
Publication status	Published - Nov-2020

Keywords

RISK MYELODYSPLASTIC SYNDROMES
CANCER
MDS

Access to Document

10.1080/10428194.2020.1775217

Embargoed Document

Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands the OCEAN study
Final publisher's version, 1.04 MB
Request copy

Cite this

Cruijsen, M., van der Velden, W. J. F. M., de Haan, A. F. J., Klein, S. K., Hoogendoorn, M., Tromp, Y., de Valk, B., van Rees, B., de Boer, F., van der Spek, E., Pruijt, J., Verdonck, L. F., Vellenga, E., Blijlevens, N., van de Loosdrecht, A. A., & Huls, G. (2020). Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study. Leukemia & Lymphoma, 61(11), 2752-2755. https://doi.org/10.1080/10428194.2020.1775217

Cruijsen, M ; van der Velden, W J F M ; de Haan, A F J ; Klein, S K ; Hoogendoorn, M ; Tromp, Y ; de Valk, B ; van Rees, B ; de Boer, F ; van der Spek, E ; Pruijt, J ; Verdonck, L F ; Vellenga, E ; Blijlevens, N ; van de Loosdrecht, A A ; Huls, G. / Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands : the OCEAN study. In: Leukemia & Lymphoma. 2020 ; Vol. 61, No. 11. pp. 2752-2755.

@article{6f5894967d1d40a0a479356e1e47405c,

title = "Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study",

keywords = "RISK MYELODYSPLASTIC SYNDROMES, CANCER, MDS",

author = "M Cruijsen and {van der Velden}, {W J F M} and {de Haan}, {A F J} and Klein, {S K} and M Hoogendoorn and Y Tromp and {de Valk}, B and {van Rees}, B and {de Boer}, F and {van der Spek}, E and J Pruijt and Verdonck, {L F} and E Vellenga and N Blijlevens and {van de Loosdrecht}, {A A} and G Huls",

year = "2020",

month = nov,

doi = "10.1080/10428194.2020.1775217",

language = "English",

volume = "61",

pages = "2752--2755",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "TAYLOR & FRANCIS LTD",

number = "11",

}

Cruijsen, M, van der Velden, WJFM, de Haan, AFJ, Klein, SK, Hoogendoorn, M, Tromp, Y, de Valk, B, van Rees, B, de Boer, F, van der Spek, E, Pruijt, J, Verdonck, LF, Vellenga, E, Blijlevens, N, van de Loosdrecht, AA & Huls, G 2020, 'Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study', Leukemia & Lymphoma, vol. 61, no. 11, pp. 2752-2755. https://doi.org/10.1080/10428194.2020.1775217

Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands : the OCEAN study. / Cruijsen, M; van der Velden, W J F M; de Haan, A F J; Klein, S K; Hoogendoorn, M; Tromp, Y; de Valk, B; van Rees, B; de Boer, F; van der Spek, E; Pruijt, J; Verdonck, L F; Vellenga, E; Blijlevens, N; van de Loosdrecht, A A; Huls, G.

In: Leukemia & Lymphoma, Vol. 61, No. 11, 11.2020, p. 2752-2755.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands

T2 - the OCEAN study

AU - Cruijsen, M

AU - van der Velden, W J F M

AU - de Haan, A F J

AU - Klein, S K

AU - Hoogendoorn, M

AU - Tromp, Y

AU - de Valk, B

AU - van Rees, B

AU - de Boer, F

AU - van der Spek, E

AU - Pruijt, J

AU - Verdonck, L F

AU - Vellenga, E

AU - Blijlevens, N

AU - van de Loosdrecht, A A

AU - Huls, G

PY - 2020/11

Y1 - 2020/11

KW - RISK MYELODYSPLASTIC SYNDROMES

KW - CANCER

KW - MDS

U2 - 10.1080/10428194.2020.1775217

DO - 10.1080/10428194.2020.1775217

M3 - Comment/Letter to the editor

C2 - 32530341

VL - 61

SP - 2752

EP - 2755

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 11

ER -